PT1272489E - Processo para a preparacao da forma i cristalina de cabergolina - Google Patents

Processo para a preparacao da forma i cristalina de cabergolina

Info

Publication number
PT1272489E
PT1272489E PT01936098T PT01936098T PT1272489E PT 1272489 E PT1272489 E PT 1272489E PT 01936098 T PT01936098 T PT 01936098T PT 01936098 T PT01936098 T PT 01936098T PT 1272489 E PT1272489 E PT 1272489E
Authority
PT
Portugal
Prior art keywords
cabergolina
preparation
crystalline form
crystalline
Prior art date
Application number
PT01936098T
Other languages
English (en)
Inventor
Attilio Tomasi
Stefania Magenes
Mario Ungari
Giuliano Ramella
Gianfranco Pallanza
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9888433&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1272489(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Publication of PT1272489E publication Critical patent/PT1272489E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
PT01936098T 2000-03-24 2001-03-19 Processo para a preparacao da forma i cristalina de cabergolina PT1272489E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0007308.0A GB0007308D0 (en) 2000-03-24 2000-03-24 Process for preparing crystalline form | of cabergoline

Publications (1)

Publication Number Publication Date
PT1272489E true PT1272489E (pt) 2004-02-27

Family

ID=9888433

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01936098T PT1272489E (pt) 2000-03-24 2001-03-19 Processo para a preparacao da forma i cristalina de cabergolina

Country Status (31)

Country Link
US (2) US6727363B2 (pt)
EP (1) EP1272489B1 (pt)
JP (1) JP4184666B2 (pt)
KR (1) KR100827558B1 (pt)
CN (1) CN1188412C (pt)
AR (1) AR032449A1 (pt)
AT (1) ATE250601T1 (pt)
AU (2) AU780747B2 (pt)
BR (1) BR0109507A (pt)
CA (1) CA2402836A1 (pt)
CZ (1) CZ20023176A3 (pt)
DE (1) DE60100858T2 (pt)
DK (1) DK1272489T3 (pt)
EA (1) EA005928B1 (pt)
EE (1) EE05088B1 (pt)
ES (1) ES2208602T3 (pt)
GB (1) GB0007308D0 (pt)
HK (1) HK1052348B (pt)
HU (1) HUP0300591A3 (pt)
IL (2) IL150985A0 (pt)
MX (1) MXPA02009283A (pt)
MY (1) MY134189A (pt)
NO (1) NO20024321L (pt)
NZ (1) NZ521316A (pt)
PE (1) PE20011140A1 (pt)
PL (1) PL358253A1 (pt)
PT (1) PT1272489E (pt)
SI (1) SI1272489T1 (pt)
SK (1) SK13582002A3 (pt)
WO (1) WO2001070740A1 (pt)
ZA (1) ZA200206045B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0007307D0 (en) * 2000-03-24 2000-05-17 Pharmacia & Upjohn Spa Crystalline form || of cabergoline
GB0007308D0 (en) * 2000-03-24 2000-05-17 Pharmacia & Upjohn Spa Process for preparing crystalline form | of cabergoline
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
AU2003218753A1 (en) * 2002-03-15 2003-09-29 Pharmacia Corporation Process for preparing crystalline form i of cabergoline
EP1507777A4 (en) * 2002-03-15 2007-03-07 Pharmacia Corp PROCESS FOR THE PREPARATION OF A CRYSTALLINE FORM I OF CABERGOLIN
IL155545A (en) * 2003-04-21 2009-12-24 Finetech Pharmaceutical Ltd Solvate form of cabergoline
CA2525104A1 (en) 2003-05-08 2004-11-25 Ivax Pharmaceuticals S.R.O. Polymorphs of cabergoline
GB0409785D0 (en) * 2004-04-30 2004-06-09 Resolution Chemicals Ltd Preparation of cabergoline
GB0515430D0 (en) * 2005-07-27 2005-08-31 Resolution Chemicals Ltd Preparation of cabergoline
US7339060B2 (en) * 2005-03-23 2008-03-04 Resolution Chemicals, Ltd. Preparation of cabergoline
GB0505965D0 (en) 2005-03-23 2005-04-27 Resolution Chemicals Ltd Preparation of cabergoline
EP1925616A1 (en) * 2006-10-26 2008-05-28 LEK Pharmaceuticals D.D. Process for the preparation of crystal forms of cabergoline via stable solvates of cabergoline
EP1953157A1 (en) 2007-01-31 2008-08-06 LEK Pharmaceuticals D.D. New crystal form of cabergoline
US8637099B2 (en) * 2007-08-29 2014-01-28 Max Zeller Sohne Ag Use of Vitex agnus castus extracts for preparing a medicament
EP4074552B1 (en) * 2021-04-16 2024-04-03 Thermo King LLC Electrical connection unit

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3019322A1 (de) 1980-05-21 1981-12-03 Merck Patent Gmbh, 6100 Darmstadt Psychopharmakon sowie verwendung von adenosinderivaten
US4526892A (en) * 1981-03-03 1985-07-02 Farmitalia Carlo Erba, S.P.A. Dimethylaminoalkyl-3-(ergoline-8'βcarbonyl)-ureas
GB2103603B (en) 1981-08-11 1985-04-11 Erba Farmitalia Ergoline derivatives
GB9205439D0 (en) 1992-03-12 1992-04-22 Erba Carlo Spa Process for the synthesis of ergoline derivatives
EP0664705B1 (en) 1993-08-18 2000-10-04 Alcon Laboratories, Inc. Compositions of ergoline derivatives for the treatment of glaucoma
EP1075278A1 (en) 1998-01-13 2001-02-14 AstraZeneca UK Limited PHARMACEUTICAL COMPOSITIONS COMPRISING A COMPOUND HAVING DOPAMINE (D 2?) RECEPTOR AGONIST ACTIVITY AND A COMPOUND (B) HAVING $g(b) 2?-ADRENORECEPTOR AGONIST ACTIVITY
BR9908953A (pt) 1998-03-27 2000-12-05 Upjohn Co Utilização de cabergolina no tratamento da sìndrome de pernas agitadas (sìndrome de ekbom)
GB0007309D0 (en) 2000-03-24 2000-05-17 Pharmacia & Upjohn Spa Crystalline form V|| of cabergoline
GB0007307D0 (en) 2000-03-24 2000-05-17 Pharmacia & Upjohn Spa Crystalline form || of cabergoline
GB0007308D0 (en) 2000-03-24 2000-05-17 Pharmacia & Upjohn Spa Process for preparing crystalline form | of cabergoline

Also Published As

Publication number Publication date
MY134189A (en) 2007-11-30
US6953854B2 (en) 2005-10-11
GB0007308D0 (en) 2000-05-17
MXPA02009283A (es) 2003-03-12
EA200201016A1 (ru) 2003-02-27
NO20024321D0 (no) 2002-09-10
CN1419554A (zh) 2003-05-21
NZ521316A (en) 2004-05-28
AU780747B2 (en) 2005-04-14
SI1272489T1 (en) 2004-02-29
EP1272489A1 (en) 2003-01-08
HK1052348B (zh) 2005-09-16
EA005928B1 (ru) 2005-08-25
ZA200206045B (en) 2003-07-29
CZ20023176A3 (cs) 2003-02-12
EE200200545A (et) 2004-04-15
US20030149067A1 (en) 2003-08-07
AU2005203071B2 (en) 2007-10-18
PL358253A1 (en) 2004-08-09
PE20011140A1 (es) 2001-11-01
AU2005203071A1 (en) 2005-08-11
AR032449A1 (es) 2003-11-12
DK1272489T3 (da) 2003-12-15
HUP0300591A3 (en) 2009-01-28
HUP0300591A2 (hu) 2003-07-28
JP2003528100A (ja) 2003-09-24
ES2208602T3 (es) 2004-06-16
SK13582002A3 (sk) 2003-04-01
JP4184666B2 (ja) 2008-11-19
US6727363B2 (en) 2004-04-27
HK1052348A1 (en) 2003-09-11
DE60100858T2 (de) 2004-07-29
AU6211001A (en) 2001-10-03
NO20024321L (no) 2002-09-10
EE05088B1 (et) 2008-10-15
KR20020081587A (ko) 2002-10-28
KR100827558B1 (ko) 2008-05-07
IL150985A (en) 2007-03-08
ATE250601T1 (de) 2003-10-15
IL150985A0 (en) 2003-02-12
US20040092744A1 (en) 2004-05-13
BR0109507A (pt) 2002-12-10
CA2402836A1 (en) 2001-09-27
CN1188412C (zh) 2005-02-09
WO2001070740A1 (en) 2001-09-27
EP1272489B1 (en) 2003-09-24
DE60100858D1 (de) 2003-10-30

Similar Documents

Publication Publication Date Title
PT1303478E (pt) Processo para a preparacao de alcanoilamidas substituidas
PT1345936E (pt) Processo para a producao do anticolinergico brometo de tiotropio
PT1105382E (pt) Metodo para a preparacao de citalopran
PT1272489E (pt) Processo para a preparacao da forma i cristalina de cabergolina
PT1232152E (pt) Processo melhorado para a preparacao de aminotetralinas substituidas no azoto
PT1181272E (pt) Processo para a preparacao de citalopram puro
PT1309555E (pt) Processo para a producao de maleato amlodipina
BR0211020B1 (pt) processo para a produÇço de um poliÉster
PT1147075E (pt) Processo para a preparacao de cloridrato de l-fenilefrina
AR028002A1 (es) Metodos para la produccion de ansamitocina
PT1345939E (pt) Processo para a preparacao de imidazotriazinonas substituidas por sulfonamida
PT1313698E (pt) Processo para a preparacao de fenilacetonitrilos substituidos
PT1432682E (pt) Processo para a preparacao de repaglinida
PT1362040E (pt) Processo para a preparacao de mesilatos de derivados de piperazina
PT1280803E (pt) Forma cristalina ii da cabergolina
PT1343750E (pt) Processo para a preparacao de derivados de fenetilamina
PT1292586E (pt) Processo para a preparacao de pirazolopirimidinonas
PT1404673E (pt) Processo tecnico de sintese para a preparacao de tropenol
DE60130137D1 (de) Kristallisationsverfahren
PT1200414E (pt) Processo para a preparacao de pirimidnas substituidas
BR0117249B1 (pt) processo para preparar uma forma de fundiÇço.
PT973769E (pt) Processo para a preparacao de eprosartan
PT1399427E (pt) Processo para a preparacao de azoxistrobina a seus analogos
PT970073E (pt) Processo para a preparacao de eprosartan
PT1240173E (pt) Processo para a preparacao de n-fosfonometilglicina